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examine the epidemiology and microbiology of bacteremia
in adult patients who hospitalized in the infectious disease
department of First Hospital, Jilin University.
Methods: A retrospective observational study involving 87
adult septicemia patients and 113 blood cultures (Oct
2010-Apr 2011) of septicemia cases was performed in the
infectious disease department, and the epidemiology and
microbiology were analysised.
Results: Among these blood cultures, 38 (33.6%) were
pathogens positive. Most common pathogen was Escherichia
coli 11 (40.7%), then Staphylococcus 5 (18.5%). Urinary
tract infections (41.4%, 36/87) were most common in these
patients. Liver abscess (10.7%, 9/87) were risk factor of
septicemia too.
Conclusions: Gram-negative bacterias is main pathogens of
septicemia in our department. Infections such as urinary
tract infections, liver abscess, and so on, should be pay
more attention.
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Background: Cryptosporidiosis is caused by protozoan
parasite Cryptosporidium spp. and leads to an
acute/chronic gastroenteritis. The incidence rate of
infection in immunosuppressed patients suffering from
diarrhea was highly reported. This study was carried out
to evaluate the proliferation of the parasite from different
sources of Iranian species of Cryptosporidium spp. and to
study its pathophysiology in immunosuppressed mice.
Methods: Mice, calves and human stools samples were
collected, centrifuged by Paraseb kit, smears were
prepared and stained with acid fast assay and examined
microscopically. Oocysts were identiﬁed, separated and
concentrated by sucrose ﬂoatation. Balb/c and C57bl/6
mice were immunosuppressed by by I.P. Dexamethasone
injection; immonusuppression was conﬁrmed by lymphocyte
proliferation, and isolated oocysts from different sources
were orally inoculated into mice. The parasite replication
was assessed daily to conﬁrm proliferation of parasite.
Among the positive samples, animals were humanely killed
and the target organs (lungs, liver, intestine, spleen)
were removed, stained with Hematoxyline Eosine for
histopathological examination.
Results: The results showed more susceptibility of C57bl/6
mice rather than the Balb/c one; therefore the infection
was developed faster in C57bl/6 mice. No histopathology
was observed in H&E stained sections of target organs
and no oocysts was detected in impression smears of both
Balb/c and C57bl/6 mice. No extra-intestinal infection was
detected in study groups, which may due to short period of
infection in experimental animals.
Conclusion: These ﬁndings emphasized more susceptibility
of immunosuppressed C57bl/6 than Balb/c mice
to Cryptosporidium spp. infection. In addition, no
histopathology were detected in a short period up to
three weeks of experimental cryptosporidiosis, which may
need longer period to allow parasite for extra-intestinal
infection.
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Objective: Our previous study has indicated that the Fas
pathway played a key role in hepatocyte apoptosis in
nutritional steatohepatitis in mice. This study aimed to
explore whether Fas mutation accelerated hepatic steatosis
and inﬂammatory inﬁltration in nutritional steatohepatitis
in mice.
Methods: Mice homozygous for the lymphoproliferation
spontaneous mutation (C57BL/6J-Faslpr) and wild type
C57BL/6J mice were fed a methionine-choline deﬁcient
(MCD) diet for three weeks to induce non-alcoholic
steatohepatitis (NASH). The role of Fas gene mutation on
NASH was assessed by comparing the severity of hepatic
steatosis and inﬂammation, mRNA and protein expression
of hepatic inﬂammatory and ﬁbrogenetic related factors,
proliferating cell nuclear antigen (PCNA) and transforming
growth factor-b1 (TGFb1).
Results: At weeks 3, MCD diet induced hepatic steatosis and
inﬂammatory inﬁltration in both of wild type and Faslpr mice.
Especially, severe hepatic injury was observed in Faslpr mice
compared with wild type mice, which was associated with
up-regulated cell proliferation factor PCNA and ﬁbrogenetic
growth factors TGFb1.
Conclusions: Faslpr mice developed more severe hepatic
injury including hepatic steatosis and inﬂammatory
inﬁltration induced by MCD diet compared with wild type
mice, which might associated with excessive release of cell
proliferation, inﬂammatory and ﬁbrogenetic factors.
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Aim: We characterize changes in liver pathology, hepatic
lipid composition and hepatic oxidative-anti-oxidative
milieu in rats given fructose enriched diet (FED) and the
PPAR-g agonist Rosiglitazone.
Methods: Sprague-Dawley rats, divided into 2 groups were
studied: Rats on standard chow diet and on FED for 6 weeks,
but in the last 2 weeks of the study period FED-rats received
Rosiglitazone (10mg/kg/day).
Results: FED rats had increase in the content
of hepatic triglyceride, cholesterol, malondialdehyde
(MDA), glutathione reductase (GSSG-R), but decrease in
phospholipids, a-tocopherol, paraoxonase (PON) levels. No
changes in adiponectin, TGF-b or in TNF-a plasma levels.
FED rats had macro and micro vesicular hepatic fat deposits
and an increase in relative ﬁbrosis area. Administration
of Rosiglitazone had decrease in the hepatic triglycerides,
MDA and GSSG-R levels, increase in hepatic phospholipids
content, PON activity. Rosiglitazone caused an increase in
adiponectin plasma and a decrease in the hepatic macro
vesicular, but no change in hepatic micro vesicular and
inﬂammatory score nor in the relative ﬁbrosis area.
Conclusions: Administration of Rosiglitazone to rats with
the MS, may improve hepatic lipid metabolism and the
hepatic oxidative-anti oxidative milieu.
